These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6355399)

  • 21. Comparison of peripheral nerve protection between insulin-based glucose control and alpha lipoic acid (ALA) in the streptozotocin (STZ)-induced diabetic rat.
    Lee KA; Lee NY; Park TS; Jin HY
    Endocrine; 2018 Jul; 61(1):58-67. PubMed ID: 29736880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Near nerve local insulin prevents conduction slowing in experimental diabetes.
    Singhal A; Cheng C; Sun H; Zochodne DW
    Brain Res; 1997 Jul; 763(2):209-14. PubMed ID: 9296561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
    Elias KA; Cronin MJ; Stewart TA; Carlsen RC
    Diabetes; 1998 Oct; 47(10):1637-42. PubMed ID: 9753304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrastructural observations on myelinated fibres in the tibial nerve of streptozotocin-diabetic rats: effect of insulin treatment.
    Britland ST; Sharma AK; Duguid IG; Thomas PK
    Life Support Syst; 1985; 3 Suppl 1():524-9. PubMed ID: 3916617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Piroxicam may reduce the rate of progression of experimental diabetic neuropathy.
    Parry GJ; Kozu H
    Neurology; 1990 Sep; 40(9):1446-9. PubMed ID: 2392233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Streptozotocin induced diabetes as a model of phrenic nerve neuropathy in rats.
    Rodrigues Filho OA; Fazan VP
    J Neurosci Methods; 2006 Mar; 151(2):131-8. PubMed ID: 16125783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
    Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
    Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of short-term effects of insulin and essential fatty acids on the slowed nerve conduction of streptozotocin diabetes in rats.
    Julu PO; Mutamba A
    J Neurol Sci; 1991 Nov; 106(1):56-9. PubMed ID: 1663993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic and hypoglycemic neuropathy--a comparison in the BB rat.
    Sima AA; Zhang WX; Greene DA
    Diabetes Res Clin Pract; 1989 May; 6(4):279-96. PubMed ID: 2752883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin reverses enhanced incorporation of 32P into polyphosphoinositides in peripheral nerve of the streptozotocin diabetic rat.
    Berti-Mattera LN; Peterson RG; Eichberg J
    J Neurochem; 1986 Dec; 47(6):1932-5. PubMed ID: 3021909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes.
    Yagihashi S; Wada R; Kamijo M; Nagai K
    Lab Invest; 1993 Mar; 68(3):296-307. PubMed ID: 8383778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of peripheral nerve myelin in experimental diabetes.
    Spritz N; Singh H; Marinan B
    J Clin Invest; 1975 May; 55(5):1049-56. PubMed ID: 123535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats.
    Moore SA; Peterson RG; Felten DL; O'Connor BL
    J Neurol Sci; 1980 Oct; 48(1):133-52. PubMed ID: 6448276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-induced hypoglycemic peripheral motor neuropathy in spontaneously diabetic WBN/Kob rats.
    Ozaki K; Sano T; Tsuji N; Matsuura T; Narama I
    Comp Med; 2010 Aug; 60(4):282-7. PubMed ID: 20819377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the effects of conventional insulin treatment and continuous insulin infusion therapy on established morphological and biochemical abnormalities of peripheral nerve in experimental diabetes.
    Britland S; Sharma A
    Diabetes Res; 1990 Nov; 15(3):143-50. PubMed ID: 2132208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathological study of evening primrose oil effects on experimental diabetic neuropathy.
    Omran OM
    Ultrastruct Pathol; 2012 Aug; 36(4):222-7. PubMed ID: 22574767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
    Davidson EP; Holmes A; Coppey LJ; Yorek MA
    Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired axonal transport of acetylcholinesterase in the sciatic nerve of alloxan-diabetic rats: effect of ganglioside treatment.
    Marini P; Vitadello M; Bianchi R; Triban C; Gorio A
    Diabetologia; 1986 Apr; 29(4):254-8. PubMed ID: 2423405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo effect of methylcobalamin on the peripheral nerve structure in streptozotocin diabetic rats.
    Yagihashi S; Tokui A; Kashiwamura H; Takagi S; Imamura K
    Horm Metab Res; 1982 Jan; 14(1):10-3. PubMed ID: 6460676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axonal atrophy in sensory nerves of the diabetic BB-Wistar rat: a possible early correlate of human diabetic neuropathy.
    Sima AA; Bouchier M; Christensen H
    Ann Neurol; 1983 Mar; 13(3):264-72. PubMed ID: 6847138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.